$VICR

VINCIARELLI PATRIZIO sold $70K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 200 shares of VICOR CORP (VICR) at $349.18 on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published May 29, 2026, 6:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 7:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the transaction is pre-planned, it is generally less informative about near-term fundamentals; it mainly updates insider activity records.

02

Market read

Traders may note the disclosure, but it is unlikely to materially change valuation without corroborating operational or guidance news.

03

What to watch

The sale size is small relative to typical market cap; 10b5-1 timing can be driven by tax/liquidity planning rather than outlook.

Relevance 6/10Novelty 4/10Timing: SEC Form 4 filed today; sale occurred on 2026-05-28.

Background

The filing is an SEC Form 4 insider transaction for Vicor Corp, reported as an open-market sale by the CEO/chairman under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/chairman sold $69.8K of shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be small and fade unless accompanied by other news.

Evidence & confidence

This is a routine Form 4 disclosure with a pre-arranged plan; it provides a datapoint on insider liquidity rather than a fresh company event.

Market effects

Minimal—single-company insider liquidity disclosure without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

If the market treats insider sales as bearish regardless of 10b5-1, the filing could still trigger short-lived selling pressure.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO who sold 200 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: